ASTRO

A prospective clinical study that compared patient-reported outcomes of a broad set of cancer patients with bone metastases demonstrates that single fraction radiation therapy (SFRT) is equally as effective as multiple fraction radiation therapy (MFRT) when pain, function and quality of life are considered, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.

Prostate cancer patients who received hypofractionated (HPFX) radiation therapy (RT) reported that their quality of life, as well as bladder and bowel function, were at similar levels before and after RT, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting. 

September 15, 2014 — The American Society for Radiation Oncology (ASTRO) released its second list of five radiation oncology-specific treatments that are commonly ordered but may not always be appropriate, as part of the national Choosing Wisely campaign, an initiative of the ABIM Foundation.

September 15, 2014 — A secondary analysis of the National Surgical Adjuvant Breast and Bowel Project B-32 trial (Krag 2010) indicates that radiation therapy does not increase the incidence of lymphedema in patients with node-negative breast cancer, according to research presented this week at the 56th annual meeting of the American Society for Radiation Oncology (ASTRO).

Patient-reported data indicates that when Manuka honey is prescribed for esophagitis pain during radiation therapy (RT), it is not more effective than standard medical care, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.